Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-22

FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for atovaquone and proguanil hydrochloride from Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (atovaquone and proguanil hydrochloride)

Snippet

SUPPL AP for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)